Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:32 am Sale | 2022-12-30 | 13G | Sarepta Therapeutics, Inc. SRPT | The Vanguard Group | 8,033,264 9.150% | -277,844 (-3.34%) | Filing History |
| 2023-01-31 5:52 pm Purchase | 2022-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT | BlackRock Inc. BLK | 5,557,234 6.300% | 272,000 (+5.15%) | Filing History |
| 2022-02-11 7:18 pm Purchase | 2021-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT | SANDS CAPITAL MANAGEMENT, LLC | 5,364,627 6.160% | 4,387,496 (+449.02%) | Filing History |
| 2022-02-11 12:13 pm Purchase | 2021-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT | JANUS HENDERSON GROUP PLC JHG | 7,245,862 8.300% | 7,245,862 (New Position) | Filing History |
| 2022-02-10 08:37 am Purchase | 2021-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT | The Vanguard Group | 8,311,108 9.540% | 1,093,849 (+15.16%) | Filing History |
| 2022-02-09 10:24 am Sale | 2022-02-08 | 13G | Sarepta Therapeutics, Inc. SRPT | FMR LLC | 2,955,056 3.391% | -3,160,172 (-51.68%) | Filing History |
| 2022-02-01 5:14 pm Sale | 2021-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT | BlackRock Inc. BLK | 5,285,234 6.100% | -93,981 (-1.75%) | Filing History |
| 2021-08-10 12:21 pm Sale | 2021-08-10 | 13G | Sarepta Therapeutics, Inc. SRPT | Capital Research Global Investors | 3,842,491 4.800% | -4,181,639 (-52.11%) | Filing History |